News & Innovation
65 million injection devices ordered
September 30, 2020
65 million injection devices ordered by the U. K. government in anticipation of COVID-19 vaccine
Finding a viable vaccine candidate
The development and distribution of a vaccine is needed to protect the global population from the coronavirus disease 2019 (COVID-19). There are approximately 100 vaccine candidates currently in development around the world, 18% of which are being developed in Europe2. An approved vaccine is anticipated for the end of this year or early 20213.
U.K. gearing up for mass vaccinations
U.K. Health Secretary Matt Hancock announced the U.K. government was, “working hard” to setup a COVID-19 vaccination programme along with the “biggest flu vaccination programme in history1.” To prepare for a large-scale vaccination campaign to protect the British population from COVID-19, the U.K. government recently ordered 65 million BD™ Flu+ Syringes4. They are expected to be delivered in September 20204. The BD™ Flu+ Syringe is intuitive and easy to use. It contains an integrated needle, which is designed to minimise waste5. During a pandemic, every dose counts. BD is also working with the National Health Service (NHS) to expand diagnostic testing in the United Kingdom4.
Anticipating injection device needs
Governments of several other European countries are discussing possible orders of BD injection devices for a future COVID-19 vaccine3. BD is encouraging governments around the world to think ahead and anticipate the large numbers of syringes and needles that will be needed once a safe and effective vaccine has been found. According to Rick Byrd, president of Medication Delivery Solutions for BD, “Proactive actions taken by the U.S., Canada and the U.K. to order injection devices now will help these countries be ready to administer a vaccine when one is approved and ready3.”
Delivering the future vaccine
The COVID-19 vaccine will probably not be delivered in prefilled syringes1. It will most likely be available in single or multidose vials1. These will require administration via separate non-prefilled syringes1. As the largest producer of injection devices in the world3, BD has the manufacturing capacity necessary to meet future demand for the COVID-19 vaccine, while supplying annual influenza vaccination and childhood vaccination campaigns3. The U.K. government prioritises vaccinating healthcare professionals first because of the risk of contracting the virus and passing it on to patients1.
Defeating this virus
Rick Byrd concluded, “BD’s commitment to manufacture hundreds of millions of needles and syringes for the global COVID-19 response reinforces the company’s dedication to helping the healthcare community control and defeat this virus3.”
#injectiondevice #needles #pandemic #publichealth #syringes #vaccination #vaccine
1.Philpotts E. Government orders 65m syringes ahead of potential Covid-19 vaccine. 14 July 2020. http://www.pulsetoday.co.uk/clinical/immunisation/government-orders-65m-syringes-ahead-of-potential-covid-19-vaccine/20041130.article (accessed 6 August 2020.
2.Thanh Le T, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov 2020; 19(5): 305-6.
3.Kirkpatrick T. BD Receives Additional Orders For 177 Million Injection Devices For U.S., Canada COVID-19 Vaccine Preparations [press release]. 21 July 2020. https://news.bd.com/2020-07-21-BD-Receives-Additional-Orders-For-177-Million-Injection-Devices-For-U-S-Canada-COVID-19-Vaccine-Preparations (accessed 6 August 2020.
4.Singh K. UK orders 65 million injection devices from Becton Dickinson for vaccine program [press release]. 3 July 2020. https://www.reuters.com/article/us-health-coronavirus-britain-bd/uk-orders-65-million-injection-devices-from-becton-dickinson-for-vaccine-program-idUSKBN2440PQ (accessed 6 August 2020.
5.Strauss K, van Zundert A, Frid A, Costigliola V. Pandemic influenza preparedness: the critical role of the syringe. Vaccine 2006; 24(22): 4874-82.
This list of references to third party peer reviewed material and the sites they are hosted on are provided for your reference and convenience only, and do not imply any review or endorsement of the material or any association with their operators. The Third Party References (and the Web sites to which they link) may contain information that is inaccurate, incomplete, or outdated. Your access and use of the Third Party Sites (and any Web sites to which they link) is solely at your own risk.
Approbation Number: BD-20524